Evidence mapPaperPMID 39826090Full record

Trial reportSleep2025

Impact and mechanisms of cognitive behavioral therapy for insomnia on fatigue among cancer survivors: a secondary analysis of a randomized controlled trial.

Krista M Greeley, Joshua Rash, Joshua Tulk, Josée Savard, Melanie Seal, Robin Urquhart, John Thoms, Kara Laing, Emily Fawcett, Sheila N Garland

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04026048 (A Randomized Controlled Trial of Online Cognitive Behavior Therapy for Insomnia), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04026048 nacompletednot on this map

A Randomized Controlled Trial of Online Cognitive Behavior Therapy for Insomnia (CBT-I) and Perceived Cognitive Impairment (PCI) in Cancer Survivors

TypeinterventionalSponsorMemorial University of NewfoundlandRan2019 to 2023Enrolled132ConditionsCancer, Insomnia, Cognitive ImpairmentArmsCognitive Behaviour Therapy for Insomnia (CBT-I)
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Joint nausea and fatigue profiles during chemotherapy identify patients with a higher symptom burden.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Krista M GreeleyDepartment of Psychology, Faculty of Science, Memorial University, St. John's, NL, Canada.ORCID 0009-0007-6076-8563
Joshua RashDepartment of Psychology, Faculty of Science, Memorial University, St. John's, NL, Canada.ORCID 0000-0003-0927-0712
Joshua TulkDepartment of Psychology, Faculty of Science, Memorial University, St. John's, NL, Canada.ORCID 0000-0001-9908-263X
Josée SavardSchool of Psychology, Université Laval, CHU de Québec-Université Laval Research Center, Université Laval Cancer Research Centre, Quebec, QC, Canada.ORCID 0000-0002-8052-1046
Melanie SealDiscipline of Oncology, Faculty of Medicine, Memorial University, St. John's, NL, Canada.
Robin UrquhartDepartment of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.ORCID 0000-0001-8864-5716
John ThomsDiscipline of Oncology, Faculty of Medicine, Memorial University, St. John's, NL, Canada.
Kara LaingDiscipline of Oncology, Faculty of Medicine, Memorial University, St. John's, NL, Canada.
Emily FawcettDepartment of Psychology, Faculty of Science, Memorial University, St. John's, NL, Canada.ORCID 0000-0002-4734-947X
Sheila N GarlandDepartment of Psychology, Faculty of Science, Memorial University, St. John's, NL, Canada.ORCID 0000-0002-6119-318X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesCancer-related fatigue is one of the most common symptoms in cancer survivors. Cognitive behavioral therapy for insomnia (CBT-I) can improve fatigue, but mechanisms are unclear. This secondary analysis of a randomized controlled trial evaluated whether CBT-I led to a significant improvement in fatigue, accounting for change in comorbid symptoms of insomnia, perceived cognitive impairment (PCI), anxiety, and depression. The parent study evaluated the impacts of CBT-I on PCI and insomnia.

methodsCancer survivors with insomnia and PCI were randomized to CBT-I or sleep-self-monitoring waitlist control. Fatigue was measured using the Multidimensional Fatigue Symptom Inventory-Short Form at pre-, mid-, and post-treatment. Significant improvement in fatigue was defined as a reduction of >10.79 points. Insomnia, PCI, anxiety, and depression symptoms were assessed. A linear mixed model evaluated whether CBT-I improved fatigue after adjusting for comorbidities. Mediation analyses examined whether change in comorbidities accounted for the effect of CBT-I on fatigue.

resultsThe sample consisted of 132 cancer survivors (77% female, Mage = 60.12 years, 41% breast cancer). There was a significant group-by-time interaction on fatigue, p < .001, with the CBT-I group experiencing a 20.6-point reduction in fatigue compared to 3.7 points in the control. Improvements in fatigue were fully accounted for by improvements in the comorbidities with change in insomnia accounting for 45.3% of the effect observed in fatigue.

conclusionsCBT-I resulted in significant improvement in fatigue, and these effects were largely accounted for by changes in insomnia. CBT-I is a robust intervention with efficacy for improving fatigue among cancer survivors. CLINICAL TRIAL INFORMATION: Online Treatment of Cognitive Impairment and Insomnia in Cancer Survivors, https://clinicaltrials.gov/study/NCT04026048?term=NCT04026048&rank=1, ClinicalTrials.gov ID: NCT04026048.

Indexed as

Cancer SurvivorsCognitive Behavioral TherapyFatigueNeoplasmsSleep Initiation and Maintenance DisordersAgedAnxietyCognitive DysfunctionDepressionFemaleHumansMaleMiddle AgedTreatment Outcomecancercancer-related fatiguecognitive impairmentinsomnia

Identifiers

PMID39826090
PMCPMC12163127

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.